BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical medical devices.
Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.
BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging ...
A Bronx council member wants to force the city’s Department of Health and Mental Hygiene to pick up used drug needles that ...